Covered recipient · General Payments record
NADER MOAVEN
Allopathic & Osteopathic Physicians Internal Medicine Infectious Disease
General Payments · PY2018–2023
$15,847.17
- Reported across 306 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $107.10 | 7 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ViiV Healthcare Company | $32.59 | 2 |
| GlaxoSmithKline, LLC. | $32.21 | 2 |
| Gilead Sciences, Inc. | $27.48 | 2 |
| Acerta Pharma LLC | $14.82 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (7)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $14.82 | 04/18/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1011578693 | CMS |
| Gilead Sciences, Inc. | $14.59 | 04/21/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1026006699 | CMS |
| Gilead Sciences, Inc. | $12.89 | 04/21/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1026047889 | CMS |
| GlaxoSmithKline, LLC. | $16.63 | 02/21/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002730833 | CMS |
| GlaxoSmithKline, LLC. | $15.58 | 03/22/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002727165 | CMS |
| ViiV Healthcare Company | $16.14 | 02/09/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1001257575 | CMS |
| ViiV Healthcare Company | $16.45 | 04/21/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1001258287 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.